Metraipolis › archive › dc_2db4627fbc37
Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized… — Europe PMC PMID:41847515
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41847515
- DOI
- 10.3389/fcvm.2026.1761093
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T09:44:19.892Z
- SHA-256 of the archived text
6b02aa5f5626668d92683d490d030a5495d85cbe91c93c7e2568becb677c0a65- Stable URL of this page
https://metraipolis.com/documento/dc_2db4627fbc37
How to cite
Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized… — Europe PMC PMID:41847515 — Europe PMC (en), https://europepmc.org/article/MED/41847515 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2db4627fbc37 (Metraipolis archive dc_2db4627fbc37, sha256 6b02aa5f5626668d92683d490d030a5495d85cbe91c93c7e2568becb677c0a65)
BibTeX
@misc{dc2db4627fbc37,
title = {Proactive, short-term PCSK9 inhibition after PCI in patients with coronary artery disease at high residual risk: rationale and design of the randomized… — Europe PMC PMID:41847515},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41847515},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2db4627fbc37; sha256 6b02aa5f5626668d92683d490d030a5495d85cbe91c93c7e2568becb677c0a65},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41847515. Agents can read the archived copy with the MCP tool read_document.